Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2008

01.10.2008 | Original Article

Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease

verfasst von: Kunitoshi Iseki, Kaori Tokashiki, Chiho Iseki, Kentaro Kohagura, Kozen Kinjo, Shuichi Takishita

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Body mass index (BMI) is a significant predictor of developing end-stage renal disease (ESRD). The relation between a change in BMI (ΔBMI) and the incidence of ESRD has not been examined in any large epidemiologic studies.

Methods

We determined the ΔBMI in subjects who participated in the Okinawa General Health Maintenance Association (OGHMA) screenings in 1983 and again in 1993. Screenees were free of ESRD at the 1993 screening and were then monitored until the end of 2000 to determine whether they developed ESRD. Participants were identified using ID numbers, birthdates, and other identifiers. Details of every ESRD patient treated in Okinawa are maintained in an independent community-based dialysis registry. Multivariate logistic analyses were performed to determine the significance of a ΔBMI on the incidence of ESRD using SAS. The ethics committee of the OGHMA approved the study protocol. Only coded data were used for this study.

Results

Among the 92,364 subjects aged 30–89 years screened in 1983, 29,011 (31.4%) returned for the 1993 screening. The median ΔBMI was 2.1%, and the subjects were divided into two groups: ΔBMI < 2.1% (G1) and ΔBMI ≥ 2.1% (G2). The cumulative incidence of ESRD was 0.31% in G1 (ESRD in 44) and 0.14% in G2 (ESRD in 21). The odds ratio (95% confidence interval) of developing ESRD based on a ΔBMI was 2.268 (1.284–4.000, P < 0.01) after adjusting for age, sex, systolic blood pressure, BMI in 1983, and proteinuria.

Conclusion

The findings of the present study suggest that a ΔBMI is an independent risk factor for the incidence of ESRD, especially for those with proteinuria. The reasons for the BMI change were not recorded in this study. Unintentional weight loss, however, might warrant evaluation for the presence or progression of chronic kidney disease.
Literatur
1.
2.
Zurück zum Zitat US Renal Data System. USRDS 2006 Annual Data Report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis. 2008;51 Suppl 1:S81–98. US Renal Data System. USRDS 2006 Annual Data Report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis. 2008;51 Suppl 1:S81–98.
3.
Zurück zum Zitat Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am. 2003;32:741–60.CrossRef Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am. 2003;32:741–60.CrossRef
4.
Zurück zum Zitat Iseki K, Kohagura K, Iseki C, et al. Changes in demographics and the prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res. 2007;30:55–62.CrossRef Iseki K, Kohagura K, Iseki C, et al. Changes in demographics and the prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res. 2007;30:55–62.CrossRef
5.
Zurück zum Zitat Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.CrossRef Iseki K, Ikemiya Y, Kinjo K, et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870–6.CrossRef
6.
Zurück zum Zitat Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–8.CrossRef Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–8.CrossRef
7.
Zurück zum Zitat Sowers JR. Metabolic risk factors and renal disease. Kidney Int. 2007;71:719–20.CrossRef Sowers JR. Metabolic risk factors and renal disease. Kidney Int. 2007;71:719–20.CrossRef
8.
Zurück zum Zitat Krikken JA, Lely AT, Bakker SJ, et al. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260–5.CrossRef Krikken JA, Lely AT, Bakker SJ, et al. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int. 2007;71:260–5.CrossRef
9.
Zurück zum Zitat Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–50.CrossRef Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–50.CrossRef
10.
Zurück zum Zitat Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–74.CrossRef Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004;140:167–74.CrossRef
11.
Zurück zum Zitat Stengel B, Tarver-Carr ME, Powe NR, et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–87.PubMed Stengel B, Tarver-Carr ME, Powe NR, et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–87.PubMed
12.
Zurück zum Zitat Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38:1802–8.PubMed Metcalf P, Baker J, Scott A, et al. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38:1802–8.PubMed
13.
Zurück zum Zitat Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRef Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRef
14.
Zurück zum Zitat Tanaka H, Shiohira Y, Uezu Y, et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRef Tanaka H, Shiohira Y, Uezu Y, et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRef
15.
Zurück zum Zitat Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRef Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRef
16.
Zurück zum Zitat Praga M, Hernandez E, Andres A, et al. Effects of body weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70:35–41.CrossRef Praga M, Hernandez E, Andres A, et al. Effects of body weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70:35–41.CrossRef
17.
Zurück zum Zitat Tozawa M, Iseki K, Iseki C, et al. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRef Tozawa M, Iseki K, Iseki C, et al. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRef
18.
Zurück zum Zitat Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16:791–9.CrossRef Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a Southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005;16:791–9.CrossRef
19.
Zurück zum Zitat Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688–703.CrossRef Kopple JD, Greene T, Chumlea WC, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688–703.CrossRef
20.
Zurück zum Zitat Chertow GM, Hsu C, Johansen KL. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol. 2006;17:1501–2.CrossRef Chertow GM, Hsu C, Johansen KL. The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol. 2006;17:1501–2.CrossRef
21.
Zurück zum Zitat Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk of chronic renal failure. J Am Soc Nephrol. 2006;17:1695–702.CrossRef Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk of chronic renal failure. J Am Soc Nephrol. 2006;17:1695–702.CrossRef
22.
Zurück zum Zitat Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453–9.CrossRef Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453–9.CrossRef
23.
Zurück zum Zitat Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800–5.CrossRef Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800–5.CrossRef
24.
Zurück zum Zitat Eijkelkamp WB, Zhang Z, Remuzzi G, et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol. 2007;18:1540–6.CrossRef Eijkelkamp WB, Zhang Z, Remuzzi G, et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol. 2007;18:1540–6.CrossRef
25.
Zurück zum Zitat Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006;17:2974–84.CrossRef Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006;17:2974–84.CrossRef
26.
Zurück zum Zitat Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRef Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRef
27.
Zurück zum Zitat Anavekar NS, McMurray JJV, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–95.CrossRef Anavekar NS, McMurray JJV, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285–95.CrossRef
28.
Zurück zum Zitat Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69:1264–71.CrossRef Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69:1264–71.CrossRef
29.
Zurück zum Zitat Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;69:228–36.CrossRef Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005;69:228–36.CrossRef
30.
Zurück zum Zitat Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50.CrossRef Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007;11:41–50.CrossRef
31.
Zurück zum Zitat Iseki K. The Okinawa screening program. J Am Soc Nephrol. 2003;14 Suppl 2:S127–30.CrossRef Iseki K. The Okinawa screening program. J Am Soc Nephrol. 2003;14 Suppl 2:S127–30.CrossRef
32.
Zurück zum Zitat National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 Suppl 1:S170–212. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 Suppl 1:S170–212.
33.
Zurück zum Zitat Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.CrossRef Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.CrossRef
34.
Zurück zum Zitat Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. J Am Soc Nephrol. 2006;69:2155–61. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. J Am Soc Nephrol. 2006;69:2155–61.
35.
Zurück zum Zitat Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82.CrossRef Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82.CrossRef
36.
Zurück zum Zitat Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing low GFR or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res. 2007;30:167–74.CrossRef Iseki K, Iseki C, Ikemiya Y, et al. Risk of developing low GFR or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res. 2007;30:167–74.CrossRef
37.
Zurück zum Zitat Iseki K, Tozawa M, Iseki C, et al. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000). Kidney Int. 2002;61:668–75.CrossRef Iseki K, Tozawa M, Iseki C, et al. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000). Kidney Int. 2002;61:668–75.CrossRef
Metadaten
Titel
Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease
verfasst von
Kunitoshi Iseki
Kaori Tokashiki
Chiho Iseki
Kentaro Kohagura
Kozen Kinjo
Shuichi Takishita
Publikationsdatum
01.10.2008
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2008
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-008-0061-6

Weitere Artikel der Ausgabe 5/2008

Clinical and Experimental Nephrology 5/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.